These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3281173)

  • 1. Effect of fenfluramine on insulin/growth hormone ratio in obese subjects.
    Altomonte L; Zoli A; Ghirlanda G; Manna R; Greco AV
    Pharmacology; 1988; 36(2):106-11. PubMed ID: 3281173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fenfluramine on growth hormone and prolactin secretion in obese subjects.
    Altomonte L; Zoli A; Alessi F; Ghirlanda G; Manna R; Greco AV
    Horm Res; 1987; 27(4):190-4. PubMed ID: 3436616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
    Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man.
    Casanueva FF; Villanueva L; Peñalva A; Cabezas-Cerrato J
    Neuroendocrinology; 1984 Apr; 38(4):302-8. PubMed ID: 6374488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hypocaloric diet with and without D-fenfluramine treatment on growth hormone release after growth hormone-releasing factor stimulation in patients with android obesity.
    Medeiros-Neto G; Lima N; Perozim L; Pedrinola F; Wajchenberg BL
    Metabolism; 1994 Aug; 43(8):969-73. PubMed ID: 8052154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired growth hormone response to insulin-induced hypoglycaemia in obese patients: restoration blocked by ritanserin after fenfluramine administration.
    Bernini GP; Argenio GF; Vivaldi MS; Del Corso C; Birindelli R; Luisi M; Franchi F
    Clin Endocrinol (Oxf); 1990 Apr; 32(4):453-9. PubMed ID: 2112069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity.
    Maccario M; Grottoli S; Razzore P; Procopio M; Oleandri SE; Ciccarelli E; Camanni F; Ghigo E
    Eur J Endocrinol; 1996 Aug; 135(2):205-10. PubMed ID: 8810734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
    Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose.
    Maccario M; Procopio M; Grottoli S; Oleandri SE; Razzore P; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3774-8. PubMed ID: 8530634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and growth hormone in lean and obese pigs.
    Wangsness PJ; Martin RJ; Gahagan JH
    Am J Physiol; 1977 Aug; 233(2):E104-8. PubMed ID: 888946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis of GH deficiency in obese patients: a reappraisal with GHRH plus arginine testing after pharmacological blockade of lipolysis.
    Scacchi M; Orsini F; Cattaneo A; Grasso A; Filippini B; Pecori Giraldi F; Fatti LM; Moro M; Cavagnini F
    Eur J Endocrinol; 2010 Aug; 163(2):201-6. PubMed ID: 20460421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
    Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific stimulation of brain serotonin mediated neurotransmission by dexfenfluramine does not restore growth hormone responsiveness in obese women.
    Kars ME; Pijl H; Cohen AF; Frölich M; Schoemaker HC; Brandenburg HC; Meinders AE
    Clin Endocrinol (Oxf); 1996 May; 44(5):541-6. PubMed ID: 8762730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
    Tanaka K; Inoue S; Numata K; Okazaki H; Nakamura S; Takamura Y
    Metabolism; 1990 Sep; 39(9):892-6. PubMed ID: 2118219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
    Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
    Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity.
    Rasmussen MH; Juul A; Kjems LL; Skakkebaek NE; Hilsted J
    J Clin Endocrinol Metab; 1995 Mar; 80(3):796-801. PubMed ID: 7533771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.